In conclusion, our data support a key role for increased ATGL and HSL activity in adipose tissue, leading to increased FA delivery and TG production in the liver in conjunction with a compromised capacity of the liver to compensate with increased hepatic lipolysis, FA oxidation and TG export in this model of NASH. Here, PNPLA2 is linked to metabolic dysfunction-associated steatohepatitis.